ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 157995 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 157995; 2) Community: the network communities that were significantly associated with the response to NSC 157995; 3) Molecule: the relationships between components within communities and NSC 157995; 4) MDR: the compounds that were significantly associated with the NSC 157995.

NSC Compound Enrichment Correlation
NSC 615035 Tetrazolium, 1-(4,5-dimethyl-2-thiazolyl)-2-phenyl-4-(4-pyridyl)-,bromide 0.0422011701988039 0.20832654
NSC 629107 2,7-Dicyanoxanthone 0.0422011701988039 0.13274525
NSC 633484 Null 0.0422011701988039 -0.18528899
NSC 644043 Null 0.0422011701988039 -0.03609673
NSC 653864 Null 0.0422011701988039 0.11264989
NSC 672453 Null 0.0422011701988039 0.15118612
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0422011701988039 -0.064097116
NSC 681636 Camptothecin Derivative 0.0422011701988039 0.43042279
NSC 683558 Camptothecin Derivative 0.0422011701988039 0.34894189
NSC 690970 Null 0.0422011701988039 -0.1051405
Total:54  Current:39    [First] [Prev] [Next] [Last]